AtheroGenics, Inc.
🏢 View company profile →26Patents
0Active
26Granted
32Portfolio score
Filing activity: May 14, 1998 → Nov 1, 2005
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6121319A | Monoesters of probucol for the treatment of cardiovascular and inflammatory disease | Chemistry; Metallurgy | 47 | Expired |
| US6147250A | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 43 | Expired |
| US6608101B1 | 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders | Human Necessities | 32 | Expired |
| US6887712B1 | Methods and compositions to lower plasma cholesterol levels | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6670398B2 | Compounds and methods for treating transplant rejection | Chemistry; Metallurgy | 28 | Expired |
| US7247714B2 | Protection against oxidative stress and inflammation by a cytoprotective response element | Chemistry; Metallurgy | 17 | Expired |
| US6548699B1 | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 16 | Expired |
| US6881860B2 | Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality | Physics | 13 | Expired |
| US6852878B2 | Thioketals and thioethers for inhibiting the expression of VCAM-1 | Chemistry; Metallurgy | 12 | Expired |
| US6602914B2 | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 10 | Expired |
| US6617352B2 | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 10 | Expired |
| US7094801B2 | Chalcone derivatives and their use to treat diseases | Chemistry; Metallurgy | 8 | Expired |
| US6828447B2 | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 5 | Expired |
| US7071158B2 | Antioxidant enhancement of therapy for hyperproliferative conditions | Human Necessities | 4 | Expired |
| US7087645B2 | Compounds and methods for treating transplant rejection | Chemistry; Metallurgy | 4 | Expired |
| US6960683B2 | Salt forms of poorly soluble probucol esters and ethers | Chemistry; Metallurgy | 3 | Expired |
| US7375252B2 | Compounds and method for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 3 | Expired |
| US7189870B2 | Compounds and methods for the inhibition of the expression of VCAM-1 | Chemistry; Metallurgy | 2 | Expired |
| US7273948B2 | Process of preparing esters and ethers of probucol and derivatives thereof | Chemistry; Metallurgy | 2 | Expired |
| US7371895B2 | Salt forms of poorly soluble probucol esters and ethers | Chemistry; Metallurgy | 2 | Expired |
| US7294737B2 | Process of preparing esters and ethers of probucol and derivatives thereof | Human Necessities | 2 | Expired |
| US6747061B2 | N-substituted dithiocarbamates for the treatment of biological disorders | Human Necessities | 1 | Expired |
| US7078431B2 | 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders | Human Necessities | 0 | Expired |
| US7183317B2 | Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality | Physics | 0 | Expired |
| US7202247B2 | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.